You are viewing: Europe Carrier Screening Market analysis
Part of: Carrier Screening Market (Global)

The Europe Carrier Screening Market was valued at $656.8 Million in 2023 and projected to reach to $1572.7 Million by 2028, representing a compound annual growth rate of 19.1%. Europe's carrier screening market is positioned for sustained expansion through 2028, driven by heightened awareness of genetic disorders, improved access to diagnostic technologies, and supportive healthcare policies across member states.

Europe Carrier Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Carrier Screening Market Trends and Insights

  • The European market is driven by increasing awareness of genetic disorders, advancing diagnostic technologies, and supportive regulatory frameworks across member states.
  • Europe's healthcare infrastructure and emphasis on preventive medicine position the region as a key growth hub for carrier screening solutions. By 2028, Europe's carrier screening market is forecast to reach $1,572.7 million, representing a compound annual growth rate of 19.1%.
  • This expansion reflects rising adoption of non-invasive prenatal testing, expanded newborn screening programs, and growing consumer demand for personalized medicine across Europe.
  • Europe's aging population and heightened focus on reproductive health further accelerate market penetration in the region. Europe's carrier screening landscape is characterized by increasing investment in genomic infrastructure and clinical adoption among healthcare providers.
  • The region's commitment to precision medicine and genetic counseling services strengthens the competitive positioning of carrier screening solutions throughout Europe..

Key Market Statistics

  • CAGR (2023-2028) 19.1% CAGR
  • Market Size, 2023 ~USD 656.8 Million
  • Forecast, 2028 ~USD 1572.7 Million
  • Geography Europe

Europe Carrier Screening Market Overview

Market Valuation & Growth :

Europe's carrier screening market reached $656.8 million in 2023 with a projected CAGR of 19.1%, expanding to $1,572.7 million by 2028, demonstrating strong regional momentum in genetic diagnostics.

Regulatory & Healthcare Infrastructure :

Supportive regulatory frameworks across EU member states and advanced healthcare infrastructure drive adoption of carrier screening technologies, with emphasis on preventive medicine and genetic risk assessment.

Germany's Market Leadership :

Germany dominates Europe's carrier screening market with $551.0 million in 2023, reflecting strong healthcare investment, robust diagnostic capabilities, and high awareness of genetic screening benefits.

Diagnostic Technology Advancement :

Increasing awareness of genetic disorders combined with advancing diagnostic technologies and next-generation sequencing capabilities accelerate carrier screening adoption across European healthcare systems.

Europe Carrier Screening Market Dynamics

  • The region's emphasis on preventive medicine and personalized healthcare creates favorable conditions for market growth.
  • Key markets including Germany, UK, and France are investing in genetic screening infrastructure, while regulatory harmonization within the EU facilitates market penetration.
  • Technological advancements in sequencing and analysis, coupled with decreasing test costs, are expected to broaden patient accessibility and drive adoption rates across diverse European populations..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Europe's carrier screening market is valued at $656.8 million in 2023 and projected to grow to $1,572.7 million by 2028.
      • Europe demonstrates a 19.1% CAGR, reflecting strong adoption of genetic testing and preventive healthcare initiatives across the region.
      • Europe's advanced healthcare infrastructure and regulatory support drive widespread implementation of carrier screening programs.
      • Europe's focus on reproductive health and personalized medicine creates sustained demand for carrier screening solutions through 2028.

      Carrier Screening Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment PULMONARY CONDITIONS (Medical Condition)
      Forecast Period 2023-2028
      Growth Rate CAGR of 19.7% from 2023 to 2028
      Largest Segment SERVICES (Product & Service)
      Market Size Base Year (Billions) ~USD 2.2 (2023)
      Revenue Forecast (Billions) ~USD 5.4 (2028)
      Segments Covered Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028

      Europe Carrier Screening Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Products
      • Services

      By Type

      • Customized Panel Testing
      • Expanded Carrier Screening
      • Predesigned Panel Testing
      • Targeted Disease Carrier Screening

      By Medical Condition

      • Hematological Conditions
      • Neurological Conditions
      • Other Medical Conditions
      • Pulmonary Conditions

      By Technology

      • Dna Microarrays
      • Dna Sequencing
      • Other Technologies
      • Pcr

      By End User

      • Clinical Laboratories
      • Fertility Clinics
      • Hospitals And Medical Centers
      • Other End Users

      By Product & 2021-2028

      • Products
      • Services

      EUROPE: CARRIER SCREENING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      CLINICAL LABORATORIES118.6138.6163.4192.8227.7269.4319381.518.5
      FERTILITY CLINICS48.255.464.474.887101.4118.3139.316.7
      HOSPITALS AND MEDICAL CENTERS280.9332.6397.3475.1568.3680.8816.298820
      OTHER END USERS24.427.731.736.441.747.95563.915
      TOTAL472.1554.3656.8779924.71099.51308.51572.719.1

      REST OF EUROPE: CARRIER SCREENING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      CLINICAL LABORATORIES12.113.91618.421.224.628.433.215.8
      FERTILITY CLINICS4.95.56.37.18.19.210.512.114
      HOSPITALS AND MEDICAL CENTERS28.833.338.845.4536272.785.917.2
      OTHER END USERS2.52.83.13.53.94.44.95.612.4
      TOTAL48.355.464.274.486.2100.2116.5136.816.3

      Target Audience

      • Diagnostic Companies & Laboratories : Need detailed market sizing and growth projections to identify expansion opportunities, benchmark performance against regional competitors, and develop targeted go-to-market strategies across European markets.
      • Healthcare Providers & Hospital Networks : Require market intelligence on carrier screening adoption rates, technology trends, and regulatory requirements to inform procurement decisions, service offerings, and genetic testing program development.
      • Investment & Private Equity Firms : Seek comprehensive market analysis and growth forecasts to evaluate investment opportunities in European diagnostic companies, assess market attractiveness, and identify acquisition targets in the carrier screening space.
      • Medical Device & Biotech Manufacturers : Need regional market data and competitive insights to guide product development, regulatory strategy, and commercialization planning for carrier screening solutions across European healthcare systems.
      • Healthcare Policy & Government Agencies : Require market research to inform genetic screening policy development, healthcare funding allocation, and regulatory frameworks that support preventive medicine initiatives and genetic disorder awareness across Europe.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 3262.7 Million · 21.5% wtd CAGR ·
      Asia Pacific
      ~USD 357.4 Million · 13.7% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 551 Million
      UKUSD 339 Million
      FranceUSD 256.1 Million
      ItalyUSD 154.2 Million
      SpainUSD 135.7 Million
      Rest Of EuropeUSD 136.8 Million

      Country market size visualization

      Germany
      USD 551 Million
      UK
      USD 339 Million
      France
      USD 256.1 Million
      Italy
      USD 154.2 Million
      Spain
      USD 135.7 Million
      Rest Of Europe
      USD 136.8 Million

      Reasons to Buy this Report

      • Regional Market Segmentation : Detailed breakdown of Europe's carrier screening market by country, including Germany ($551.0M), UK ($339M), France ($256.1M), Italy, Spain, and Rest of Europe, enabling targeted market entry strategies.
      • Growth Trajectory Insights : Comprehensive analysis of the 19.1% CAGR trajectory from 2023 to 2028, with forecasted market expansion to $1,572.7 million, supporting strategic planning and investment decisions.
      • Regulatory & Competitive Landscape : In-depth understanding of supportive EU regulatory frameworks, healthcare infrastructure advantages, and competitive dynamics across European markets to inform market positioning and compliance strategies.
      • Technology & Innovation Trends : Analysis of advancing diagnostic technologies, next-generation sequencing adoption, and preventive medicine emphasis driving market growth and creating opportunities for diagnostic solution providers.
      • Strategic Market Opportunities : Identification of high-growth segments and underserved markets within Europe, enabling stakeholders to prioritize expansion efforts and optimize resource allocation across the region.

      Frequently asked questions

      What is the current size of Europe's carrier screening market?

      Europe's carrier screening market was valued at $656.8 million in 2023 and is expected to reach $1,572.7 million by 2028.

      What is the growth rate for carrier screening in Europe?

      Europe's carrier screening market is growing at a compound annual growth rate of 19.1% from 2023 to 2028.

      What factors are driving growth in Europe's carrier screening market?

      Growth in Europe is driven by increased genetic disorder awareness, advancing diagnostic technologies, supportive regulatory frameworks, and rising adoption of non-invasive prenatal testing.

      Which European countries are leading in carrier screening adoption?

      Europe's advanced healthcare infrastructure and regulatory support are distributed across member states, with strong adoption in countries with established genomic medicine programs.

      How does Europe's carrier screening market compare to global trends?

      Europe's 19.1% CAGR aligns closely with the global 19.7% CAGR, demonstrating that Europe is a key contributor to worldwide carrier screening market expansion.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

      Primary Research

      Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).

      The following is a breakdown of the primary respondents:

      Breakdown of Primary Participants:

      Carrier Screening Market  Size, and Share

      Note 1: Others include sales managers, marketing managers, and product managers.

      Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and markets have been identified through extensive secondary research
      • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Carrier Screening Market  Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Carrier Screening Market  Size, and Share

      Data Triangulation

      After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.

      Market Definition

      Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.

      Market Stakeholders

      • Carrier screening product manufacturers, vendors, and distributors
      • Carrier screening service companies
      • Hospitals and private physician clinics
      • Reference laboratories
      • Donor banks
      • Health insurance payers
      • Research & consulting firms
      • Diagnostic Centers, and Medical Colleges
      • Research Institutes
      • Clinical Laboratories
      • Distributors of Carrier Screening Products and services

      Report Objectives

      • To define, describe, and forecast the global Carrier Screening Market based on Product & Service, Type, Medical Condition, Technology, End User, and Region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)  
      • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
      • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
      • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Carrier Screening Market.

      Available Customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
      • Geographic Analysis:  Further breakdown of the European Carrier Screening Market into specific countries.  

      Get the Full Carrier Screening Market Report

      Full forecast, segment splits, and company analysis for all Carrier Screening Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status